Unique ID issued by UMIN | UMIN000021523 |
---|---|
Receipt number | R000024821 |
Scientific Title | Health promotion research with methods of behavioral economics |
Date of disclosure of the study information | 2016/03/17 |
Last modified on | 2016/03/26 19:02:33 |
Health promotion research with methods of behavioral economics
Health economy research of adherence
Health promotion research with methods of behavioral economics
Health economy research of adherence
Japan |
Chronic renal failure
Nephrology |
Others
NO
This study aims to develop a new theory regarding incentives to modify behavior through structuring of patient behavior using behavioral economics which discusses issues overlapping with limitations of health promotion practice.
Others
1) Studies of patient behavior modification by applying prospect theory: to evaluate the theory of promoting improvement in adherence to medical treatment for renal failure in patients with cardiovascular diseases and diabetes by focusing on the endowment effect and status quo biases.
2) Study on patient behavior modification by using heuristics: to evaluate and confirm the theory of promoting improvement in health behavior and adherence to medical treatment for renal failure in outpatients with cardiovascular disease and diabetes by focusing on the capacity for adaptation and anchoring.
Exploratory
Others
Not applicable
"Amount of behavior modification"
:change in medication dosage (unit: optimal dosage of medication / ideal dosage of medication)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Educational,Counseling,Training
Behavior,custom |
Health Consultation(Medication Teaching, Exercising Guidance, Nutrition Guidance)
- Intervention period: One month (baseline)
- Intervention frequency: Four times a month (a standard)
- Term for evaluation: Post six months (a standard)
20 | years-old | <= |
70 | years-old | > |
Male and Female
This study includes patients less than 70 years of age with chronic and end-stage renal failure taking phosphate binders, such as Fosrenol, sevelamer, and calcium carbonate.
1) Patients with chronic and end-stage renal failure
2) Patients at least 20 but less than 70 years of age
3) Patients able to visit the hospital regularly
4) Patients without serious systemic diseases or functional disorders
5) Sex: male or female
6) Patients taking a phosphate binder
The following are criteria for exclusion from this study in terms of the reliability of assessing the study endpoint.
1) Clinical findings
A. Mental disorder
B. Malignant tumors
C. A history of concomitant active infection
D. Poorly controlled diabetes
2) Others
- Patients with marked restriction of activities of daily living (severity)
- Participants in a clinical study/ trial
In addition, patients judged to be ineligible by the attending physicians are to be excluded from this study.
100
1st name | |
Middle name | |
Last name | Tomoyuki Takura |
Osaka University
Graduate School of Medicine
2-2, Yamadaoka Suita-shi, Osaka
06-6879-3401
takura@heip.med.osaka-u.ac.jp
1st name | |
Middle name | |
Last name | Tomoyuki Takura |
Osaka University
Graduate School of Medicine
2-2, Yamadaoka Suita-shi, Osaka
06-6879-3401
takura@heip.med.osaka-u.ac.jp
Osaka University
Japan Society for the Promotion of Science
Non profit foundation
Japan
Tohoku University, Juntendo University, Kyoto University, Hyogo College Of Medicine
NO
東北大学付属病院(宮城)、順天堂大学病院(東京都)、兵庫医科大学病院(兵庫)
2016 | Year | 03 | Month | 17 | Day |
Unpublished
Preinitiation
2016 | Year | 02 | Month | 10 | Day |
2016 | Year | 03 | Month | 18 | Day |
2016 | Year | 03 | Month | 17 | Day |
2016 | Year | 03 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024821